Pet Industry News
The deals, launches, and strategic moves behind the brands and operators shaping the industry.
Pets will shape travel plans for 68% of owners, Subaru survey finds
A Subaru-commissioned Talker Research survey of 2,000 pet-owning drivers, released October 13th, 2026, says 68% expect their pet to affect travel plans this year and 73% would drive instead of fly to bring the pet. New in this release, 10% may host, 10% may shorten a trip and 8% may skip gatherings. In our view, the trip-length and planning numbers are the ones sitters and kennels can use.
Luxturna's Breakthrough Prize Has a $3B Footnote for Animal-Health Biotech
Penn Medicine and Children's Hospital of Philadelphia won the 2026 Breakthrough Prize in Life Sciences for Luxturna, the first FDA-approved gene therapy for an inherited disease. The therapy was validated in a colony of blind Briard dogs at Penn Vet. Roche paid $4.3B for Spark Therapeutics to acquire it, then later wrote down $3B. The footnote matters for the animal-health biotechs using the same playbook.
U.S. Shelter Deaths Hit Sharpest Decline Since 2020 as 68% of Shelters Reach No-Kill
Best Friends Animal Society's 2025 data shows the sharpest drop in U.S. shelter deaths in five years. Dog euthanasia fell 8.5% for the first time since 2020, 68% of shelters are now no-kill, and Gen Z is driving record cat adoption rates. Four million pets found homes, expanding the addressable market for every business in the pet economy.
Sparkle Grooming Hits 500 Franchise Licenses in Under Two Years, Betting the Future on Quick-Service Pet Care
Sparkle Grooming Co. has awarded 500 franchise licenses across 27 states in under 24 months, reporting 73% membership conversion and 7% annual attrition. The "Quick-Service Pet Care" model pairs high-frequency maintenance visits with full-service grooming — a category-creation bet on franchise-scale membership economics.
Gallant's Feline OA Stem Cell Therapy Posts Positive Pilot Data, Wins FDA Fast-Track Eligibility
Gallant reported positive pilot data for its IV stem cell therapy targeting feline osteoarthritis and received FDA eligibility for the expanded conditional approval pathway. The regenerative approach competes directly with Zoetis's mAb franchise, opening a new front in the race to own pet OA treatment.
SC Johnson Takes Mrs. Meyer's Into Pet Care, Signaling CPG's Next Land Grab
SC Johnson launched Mrs. Meyer's for Pets, a six-product grooming line already stocked at PetSmart and Amazon, paired with a Westminster Kennel Club TikTok campaign. When an $11 billion CPG company enters pet care with dedicated products and a marquee partnership, indie pet brands should take note.
Zoetis Gets Wall Street's Top Bet as the OA Pain Market Enters Its Next Phase
Citi named Zoetis its top pick in animal health with a $145 price target, betting that Solensia will recover and next-gen OA drugs Lenivia and Portela will drive the next growth cycle. The same day, stem cell startup Gallant reported positive feline OA data, signaling that Zoetis won't own this category unopposed.